Bifidobacterium
longum is a very abundant organism found in the large intestine.
It is among the first colonizers of the sterile digestive
tract of newborns and predominate in breast-fed infants. It
is well recognized as a close relative of the B. lactis/bifidum
and the B. infantis family of Bifidobacterium. |
• |
It produces
lactic and acetic acids that lower the intestinal pH and further
inhibit the undesirable bacteria. |
• |
It plays a role in preventing
the colonization of invading pathogenic bacteria by attaching
to the intestinal wall and crowding out unfriendly bacteria
and yeast. |
• |
It has a high affinity
for intestinal colonization, improving the intestinal environment,
which leads to better regularity. |
• |
B. longum has, in clinical
studies, been found to reduce the frequency of gastrointestinal
disorders (diarrhea, nausea, etc.) during antibiotic use. |
• |
It produces important
B vitamins. |
• |
Alleviates lactose intolerance
symptoms. |
• |
It has also been found
to substantially inhibit the formation of colon and mammary
gland tumors in laboratory animals. |
• |
It eliminates the nitrates
commonly found in foods ingested by humans. Normal levels
of nitrates ingested by humans are not able to destroy this
strain. |
| SPECIFICATIONS |
| S.NO |
TEST |
Specification |
| 01 |
Description |
Light brown colored powder with characteristic
odour. |
| 02 |
Identification |
Gram-positive rods. |
| 03 |
Moisture Content |
Not more than 5% |
| 04 |
Stability |
Stable at cold temperature (preferably
4°C - 8°C) in dry place |
| 05 |
Viability Count |
NLT 20 Billion CFU/gram |
| 06 |
Pathogens tested for
1.Escherichia coli
2.Salmonella species
3.Staphylococcus aureus
4.Pseudomonas aeruginosa |
Absent |
| 07 |
Yeast and Mould count |
<50 CFU/gram |
|
| Bulk powder. Customized
strength of capsules and sachets in combination with other probiotics
are manufactured. |
